Goals: To estimate the average annual cost of managing a patient with chronic hepatitis B (CHB) disease in Australia. Background: Little is known about the prevalence or economic burden of hepatitis B viral (HBV) infection in Australia, despite it being recognized as a significant cause of morbidity and mortality.
|Pages (from-to)||187 - 192|
|Number of pages||6|
|Journal||Journal of Clinical Gastroenterology|
|Publication status||Published - 2004|